What does Rakesh Jhunjhunwala see in Jubilant Life Sciences?
Within a year, the investing legend has doubled down on his latest pharma bet
Himanshu Kakkar - May 23, 2020
How Biocon has been leading from the front | Editor's Note
Kiran Mazumdar Shaw's bold biologics bet is set to reap rewards
N Mahalakshmi - April 25, 2020
Just what the doctor ordered
The Indian pharma industry has a stellar decadal run and it’s not going to change anytime soon
December 23, 2017